Status:
COMPLETED
Endothelial Function and IMT in Survivors of Hodgkin's Lymphoma
Lead Sponsor:
Sheba Medical Center
Conditions:
Hodgkin's Lymphoma
Eligibility:
All Genders
18-50 years
Brief Summary
The aim of the proposed study is to assess endothelial function and IMT, as correlates of cardiovascular disease (CVD), in young adult Hodgkin's disease (HD) survivors, and to relate endothelial funct...
Detailed Description
Disease free survival of Hodgkin's disease (HD) patients has improved dramatically over the past few decades. With the dramatic advance in patient's survival, the prevention and treatment of long-term...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Hodgkin's disease survivors over 18 years old
Exclusion
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT00428688
Start Date
July 1 2009
End Date
August 1 2014
Last Update
April 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Endothelaial function lab, The Heart Institute, Sheba Medical Center, Israel
Ramat Gan, Israel, 52621